Anti-psoriatic drug anthralin activates EGF receptor/ERK and p38 signaling pathways via reactive oxygen species

✍ Scribed by Vasa, M.; Peus, D; Beyerle, A; Pott, M; Vasa, R; Pittelkow, M

• Book ID: 122488373
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 167 KB
• Volume: 16
• Category: Article
• ISSN: 0923-1811
• DOI: 10.1016/S0923-1811(98)84226-6